This article is sponsored by Pfizer. This website is neither owned, nor controlled by Pfizer. Pfizer is not responsible for the content or services of this site
New resource center available with information for women about managing symptoms of postmenopausal vaginal atrophy
SCOTTSDALE, AZ (July 10, 2013) – Characterized as a generation who led the sexual revolution in the sixties, many baby boomer women are reluctant to talk with their partners or healthcare professionals about the conditions they’re experiencing as a result of menopause. While this discussion remains taboo, it’s important for women to understand that menopause is a natural part of aging and they are not alone.
“With the average age of menopause at 51 and women living into their 80s, they are living more than one third of their lives in postmenopause,” said Dr. Lauren Streicher, Assistant Clinical Professor of Obstetrics and Gynecology at Northwestern University’s medical school. “While some menopausal symptoms are more transient, such as hot flashes, night sweats and mood swings, there are other longer-lasting postmenopausal symptoms that many women are experiencing but fewer may have heard of.”
These postmenopausal symptoms may include vaginal burning, itching and dryness, painful intercourse, urinary urgency and painful urination and may be due to lower levels of estrogen produced by the postmenopausal body. Lower levels of estrogen can cause thinning of the tissues in the vagina and lower urinary tract, resulting in a condition called postmenopausal vaginal atrophy.
“It’s time that women learn more about these symptoms, how to have a productive conversation with their doctor and that there are effective treatment options for this medical condition,” said Dr. Streicher.
Although some women may feel uncomfortable or embarrassed at the thought of discussing their postmenopausal vaginal atrophy symptoms, it is important for them to understand that they are not alone; at least one-third of women experience some vaginal symptoms after menopause. Women should be prepared to bring up their postmenopausal symptoms with their doctor to learn about the available prescription medications that are approved by the FDA to treat these symptoms.
EmpowHER, an award-winning social health company for women, is launching an online Postmenopausal Vaginal Atrophy Resource Center on EmpowHER.com. Women can visit the resource center to gain an understanding and knowledge of the symptoms of postmenopausal vaginal atrophy and learn about available treatment options, like ESTRING® (estradiol vaginal ring). The resource center was developed through a partnership with ESTRING®, which is used after menopause to treat moderate to severe vaginal itching, burning and dryness, painful intercourse, urinary urgency, and painful urination due to urogenital atrophy.
ESTRING® (estradiol vaginal ring) is a soft, flexible ring that is about 2 inches in diameter. Once inserted, ESTRING® (estradiol vaginal ring) works to help relieve these symptoms by releasing a steady, low dose of estradiol for a 90-day treatment period. So after you insert one, you do not have to remember to insert it every day. Estrogens increase the risk of cancer of the uterus. Estrogens should be used only as long as needed. You and your healthcare provider should talk regularly (such as every 3 to 6 months) about continued use of estrogen-containing products like ESTRING® (estradiol vaginal ring). You should discuss the potential benefits and risks of ESTRING® (estradiol vaginal ring) with your health care provider. Do not use ESTRING® (estradiol vaginal ring) if you have unusual vaginal bleeding, have or have had cancer of the breast or uterus, had a stroke or heart attack, have or have had blood clots or liver problems, are allergic to any of its ingredients, or think you may be pregnant. Additional Important Safety Information is available at the bottom of the article.
For more information on ESTRING®(estradiol vaginal ring), please see the Important Safety Information on this page or access the full Prescribing Information, including Boxed Warning and Patient Information on ESTRING®.com.
Through the Postmenopausal Vaginal Atrophy Resource Center, women can learn more about the condition and how to manage the symptoms, advocate for their health and find support through real women’s experiences and personal stories.
“While we do see this trend changing, for some women postmenopausal vaginal atrophy can still be a taboo topic for many women who may feel uncomfortable talking about their symptoms with their healthcare professional,” says EmpowHER Founder, Michelle King Robson. “Women do not need to suffer in silence. It is important to educate women about the condition so they can start advocating for their health.”
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at www.pfizer.com.
ESTRING® (estradiol vaginal ring) is used after menopause to treat moderate to severe vaginal itching, burning and dryness, painful intercourse, urinary urgency, and painful urination due to urogenital atrophy.
ESTRING® (estradiol vaginal ring) should be removed after 90 days of continued use. Do not use ESTRING® (estradiol vaginal ring) if you have unusual vaginal bleeding, have or have had cancer of the breast or uterus, had a stroke or heart attack, have or have had blood clots or liver problems, are allergic to any of its ingredients, or think you may be pregnant. Additional Important Safety Information is available at the bottom of the article.
The most frequently reported side effects are headaches, increased vaginal secretions, vaginal discomfort, abdominal pain, and genital itching.
Call your health care provider right away if you have any of the following warning signs: breast lumps, unusual vaginal bleeding, dizziness and faintness, changes in speech, severe headaches, chest pain, shortness of breath, pain in your legs, or changes in vision.
Carefully follow instructions for use. If you have difficulty removing ESTRING® (estradiol vaginal ring), contact your healthcare provider right away. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‐800‐FDA‐1088.
Press Contact for EmpowHER
Press Contact for Pfizer/ESTRING (estradiol vaginal ring)®
Rachel Edery Edelman